Roble, Belko & Company »

Precigen shares owned by Roble, Belko & Company

Quarter-by-quarter ownership of Precigen (PGEN) shares owned by Roble, Belko & Company from 13F filings

Historical chart of Roble, Belko & Company investment in Precigen

Tip: Access up to 7 years of quarterly data

All positions including Precigen held by Roble, Belko & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Precigen by Roble, Belko & Company

Quarter filed Position value Share count Share price at filing
2024-03-31 $0 10 0.00
2023-12-31 $0 10 0.00

More positions owned by Roble, Belko & Company

Vanguard Index Fds Etf (VTI)
Vanguard Star Fds Etf (VXUS)
Vanguard Bd Index Fds Etf (BND)
Vanguard Tax-managed Fds Etf (VEA)
Vanguard Intl Equity Index Etf (VEU)
Vanguard Whitehall Fds Etf (VYM)
Spdr S&p 500 Etf Tr Etf (SPY)
Select Sector Spdr Tr Etf (XLK)
Ishares Tr Blackrock Ultra Etf (ICSH)
Vanguard Whitehall Fds Etf (VYMI)
Ishares Tr Rus 1000 Grw Etf Etf (IWF)
Vanguard Index Fds Etf (VV)
Schwab Strategic Tr Etf (SCHB)
Vanguard Scottsdale Etf (VGIT)
Vanguard Index Fds Etf (VNQ)

View all positions for Roble, Belko & Company

Top funds holding Precigen

Patient Capital Management
Vanguard Group
Millennium Management
Iridian Asset Management
Jpmorgan Chase & Co
Opaleye Management
D. E. Shaw & Co
Charles Schwab Investment Management
Sanders Morris Harris
GSA Capital Partners
Citadel Advisors
Emfo
Bank of New York Mellon
Jacobs Levy Equity Management
Bank of America Corporation

View all funds holding Precigen